3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine, 97%, 1g

(2S)-2-[(4-{[(2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid, 98%, 100mg

4,4,5,5-Tetramethyl-2-(3-((o-tolyloxy)methyl)phenyl)-1,3,2-dioxaborolane, 97%, 1g

Attacco rapido Attacco femmina dritto, Gesch. per, Tubo interno 3,2 mm, sì, 1 pezzo

4-Oxazolecarboxylic acid, 97.0%, 1g

6-Phenylnicotinic acid, 97.0%, 25g

Methyl 4-fluoropyrazolo[1,5-a]pyridine-3-carboxylate, 97.0%, 5g

1-tert-Butyl 4-methyl 4-methylpiperidine-1,4-dicarboxylate, 95.0%, 5g

3-formyl-2,4,6-trimethylbenzyl acetate, 95.0%, 1g

2-(Dimethylamino)-N-hydroxy-N-methylacetamide, 95.0%, 250mg

5-Methylpyridazine-3-carbonitrile, 95.0%, 500mg

N,N'-1,4-Phenylenebisacetamide, 98.0%, 5g

2-Chloro-4-fluorophenylacetic acid, 98.0%, 25g